Clinical Trial Update: A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis [Phase 2]

View source ↗

Summary

This clinical trial entry describes a Phase 2 dose-ranging study to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of Galvokimig in adult…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Galvokimig

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Atopic Dermatitis | Phase 2 | Status: RECRUITING